DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,853,913 | -19.6% | 27,194 | -15.4% | 4.01% | -15.3% |
| Q4 2022 | $8,528,076 | +2.0% | 32,130 | -0.7% | 4.73% | -5.6% |
| Q3 2022 | $8,357,000 | +2.1% | 32,354 | +0.2% | 5.01% | +11.6% |
| Q2 2022 | $8,183,000 | -16.7% | 32,279 | -3.7% | 4.49% | +6.5% |
| Q1 2022 | $9,827,000 | -10.1% | 33,502 | +0.8% | 4.22% | -0.6% |
| Q4 2021 | $10,934,000 | +8.7% | 33,233 | +0.6% | 4.24% | +4.3% |
| Q3 2021 | $10,061,000 | +6.2% | 33,048 | -6.4% | 4.07% | +9.1% |
| Q2 2021 | $9,472,000 | +18.2% | 35,295 | -0.9% | 3.73% | +13.2% |
| Q1 2021 | $8,014,000 | -4.1% | 35,606 | -5.4% | 3.30% | -5.6% |
| Q4 2020 | $8,360,000 | +16.1% | 37,633 | +12.5% | 3.50% | -21.1% |
| Q3 2020 | $7,202,000 | +16.8% | 33,447 | -4.1% | 4.43% | +16.2% |
| Q2 2020 | $6,167,000 | +23.5% | 34,876 | -3.3% | 3.81% | +7.6% |
| Q1 2020 | $4,993,000 | -12.8% | 36,076 | -3.3% | 3.54% | +3.8% |
| Q4 2019 | $5,723,000 | +6.1% | 37,289 | -0.2% | 3.42% | -3.8% |
| Q3 2019 | $5,396,000 | -0.8% | 37,364 | -1.8% | 3.55% | +1.9% |
| Q2 2019 | $5,440,000 | +1.3% | 38,064 | -6.4% | 3.48% | -1.6% |
| Q1 2019 | $5,369,000 | +27.2% | 40,671 | -0.7% | 3.54% | +10.2% |
| Q4 2018 | $4,222,000 | -5.0% | 40,941 | +0.1% | 3.21% | +10.0% |
| Q3 2018 | $4,443,000 | +10.3% | 40,891 | +0.2% | 2.92% | +2.7% |
| Q2 2018 | $4,028,000 | +0.9% | 40,821 | +0.1% | 2.84% | -4.7% |
| Q1 2018 | $3,992,000 | +5.2% | 40,771 | -0.3% | 2.98% | +4.1% |
| Q4 2017 | $3,795,000 | +8.7% | 40,886 | +0.5% | 2.86% | +4.1% |
| Q3 2017 | $3,490,000 | +1.8% | 40,686 | +0.1% | 2.75% | -2.1% |
| Q2 2017 | $3,428,000 | -1.4% | 40,626 | 0.0% | 2.81% | -5.4% |
| Q1 2017 | $3,475,000 | +8.8% | 40,626 | -1.0% | 2.97% | +0.7% |
| Q4 2016 | $3,193,000 | +3.8% | 41,026 | +4.6% | 2.95% | +2.4% |
| Q3 2016 | $3,075,000 | -22.4% | 39,232 | 0.0% | 2.88% | -24.3% |
| Q2 2016 | $3,962,000 | +5.5% | 39,232 | -0.9% | 3.80% | +3.8% |
| Q1 2016 | $3,754,000 | +2.1% | 39,574 | 0.0% | 3.66% | +3.0% |
| Q4 2015 | $3,676,000 | +8.4% | 39,574 | -0.6% | 3.56% | -1.4% |
| Q3 2015 | $3,391,000 | -4.5% | 39,799 | -4.1% | 3.61% | +9.9% |
| Q2 2015 | $3,551,000 | +0.0% | 41,483 | -0.8% | 3.28% | -3.1% |
| Q1 2015 | $3,550,000 | -0.7% | 41,813 | +0.3% | 3.39% | -4.7% |
| Q4 2014 | $3,574,000 | – | 41,695 | – | 3.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |